Tildren is indicated for the control of clinical signs associated with navicular syndrome in horses.
Do not use in horses with impaired renal function or with a history of renal disease. NSAIDs should not be used concurrently with Tildren. Concurrent use of NSAIDs with Tildren may increase risk of renal toxicity and acute renal failure.
Horses should be observed closely for 4 hours post-infusion for the development of clinical signs consistent with colick or other adverse reactions.